|
|
|
Volumn 48, Issue SEPT., 2002, Pages 1487-1492
|
|
New drugs with novel therapeutic characteristics. Have they been subject to randomized controlled trials?
a
a
NONE
(Canada)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMFEBUTAMONE;
BRIMONIDINE;
CELECOXIB;
CISAPRIDE;
GABAPENTIN;
LATANOPROST;
LOSARTAN;
MONTELUKAST;
NEFAZODONE;
NEW DRUG;
OLANZAPINE;
PLACEBO;
RISPERIDONE;
SILDENAFIL;
SUMATRIPTAN;
TETRAHYDROLIPSTATIN;
ZOPICLONE;
ARTICLE;
ASTHMA;
CANADA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DRUG EFFICACY;
DRUG INFORMATION;
DRUG MARKETING;
DRUG SAFETY;
EPILEPSY;
ERECTILE DYSFUNCTION;
GASTROINTESTINAL DISEASE;
GASTROINTESTINAL MOTILITY;
GLAUCOMA;
HUMAN;
HYPERTENSION;
HYPNOSIS;
MEDLINE;
MIGRAINE;
OBESITY;
OSTEOARTHRITIS;
PHYSICIAN;
PUBLISHING;
RANDOMIZED CONTROLLED TRIAL;
RHEUMATOID ARTHRITIS;
SCHIZOPHRENIA;
SMOKING CESSATION;
CANADA;
DRUG EVALUATION;
DRUG THERAPY;
DRUGS, INVESTIGATIONAL;
HUMANS;
INFORMATION DISSEMINATION;
PUBLISHING;
RANDOMIZED CONTROLLED TRIALS;
|
|
EID: 0036750007
PISSN: 0008350X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (10)
|
|
References (8)
|
